Why is STAAR Surgical stock climbing today?

STAAR Surgical's stock climbed 2.0% in after-hours trading following the Board of Directors' authorization of a $50 million share repurchase program. The company announced the plan shortly after the regular market session concluded. The board authorized the repurchase of up to $50 million of its outstanding common stock through various means, with management having discretion over the timing and amount.

The program will last for twelve months, though the board can extend or shorten it if necessary. At the time of the announcement, STAAR had no outstanding debt and held $181.5 million in cash, equivalents, and investments available for sale. The company also had approximately 50.1 million shares of common stock outstanding as of August 7, 2026.

Analysts had lowered their price target for STAA to $23 from $28 the previous day, but the buyback news helped offset this mild headwind in after-hours trading. The broader market provided little assistance to the move, with the S&P 500, Dow Jones, and NASDAQ all experiencing slight declines during the regular session. STAAR's 52-week range of $15.59 to $35.87 demonstrates the recovery potential that investors may be pricing in, as the shares remain trading below their annual peak.

This stock price movement reflects a straightforward market reaction to a capital-return program announced by a debt-free company with substantial cash reserves, which is typically seen as a vote of confidence from the board in the stock's intrinsic value.